Effects of docetaxel on circulating immune cell subsets and association with outcomes in metastatic castration-sensitive prostate cancer.

Authors

null

Elias Chandran

Center for Immuno-Oncology, NCI, NIH, Bethesda, MD

Elias Chandran , Meghali Goswami , Renee Nicole Donahue , Mohammad O. Atiq , Fatima Karzai , Marijo Bilusic , Jennifer L. Marte , Philip M. Arlen , Lisa M. Cordes , Helen Owens , Megan Hausler , Amy Hankin , Monique Williams , William L. Dahut , William Douglas Figg , Jeffrey Schlom , James L. Gulley , Ravi Amrit Madan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer - Advanced

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

NCT02649855

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 207)

DOI

10.1200/JCO.2023.41.6_suppl.207

Abstract #

207

Poster Bd #

F8

Abstract Disclosures